Litcius/Paper detail

Prolactin receptor expression as a novel prognostic biomarker for triple negative breast cancer patients

Behnaz Motamedi, Hossain‐Ali Rafiee‐Pour, Mohammadreza Khosravi, Amirhosein Kefayat, Azar Baradaran, Elham Amjadi, Parvin Goli

2020Annals of Diagnostic Pathology27 citationsDOI

Topics & Concepts

Prolactin receptorBiomarkerBreast cancerImmunohistochemistryTriple-negative breast cancerCancerInternal medicineOncologyLymph nodeStage (stratigraphy)Survival analysisMedicineBiologyProlactinHormoneBiochemistryPaleontologyBreast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchCancer-related Molecular Pathways
Prolactin receptor expression as a novel prognostic biomarker for triple negative breast cancer patients | Litcius